Teton Advisors »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Teton Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Teton Advisors from 13F filings

Historical chart of Teton Advisors investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Teton Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Teton Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $324k 300k 1.08
2024-09-30 $357k 300k 1.19
2024-06-30 $552k 500k 1.10
2024-03-31 $488k 500k 0.98
2023-12-31 $466k 500k 0.93
2023-09-30 $375k 400k 0.94

More positions owned by Teton Advisors

Ducommun Equity (DCO)
Nathan's Famous Equity (NATH)
Distribution Solutions Group Equity (DSGR)
Gencor Industries Equity (GENC)
Eastern Co/the Equity (EML)
Myers Industries Equity (MYE)
Park-ohio Holdings Corp Equity (PKOH)
Foster Equity (FSTR)
Cts Corp Equity (CTS)
Gibraltar Industries Equity (ROCK)
Flushing Financial Corp Equity (FFIC)
Limoneira Equity (LMNR)
Astec Industries Equity (ASTE)
Golden Entertainment Equity (GDEN)
Kkr & Co Equity (KKR)

View all positions for Teton Advisors

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Camden Asset Management
Lazard Asset Management
Millennium Management
MacKay Shields
Advent Capital Management
Calamos Advisors
Citadel Advisors
Wolverine Asset Management
Bank Of Montreal
Glazer Capital
State Street Corporation
CNH Partners
DeepCurrents Investment Group
BlackRock

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1